FDA Clears New Neurostimulation System for Chronic Pain FDA Clears New Neurostimulation System for Chronic Pain

The US Food and Drug Administration has approved the Proclaim Plus spinal cord stimulation system with FlexBurst360 therapy, which provides personalized coverage at up to six pain points.FDA Approvals
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Neurology & Neurosurgery News Alert Source Type: news